Assoc Prof Dr Jia Zeng, Shanghai Institute for Biomedical and Pharmaceutical Technologies, China
Jia Zeng, a dedicated research backbone at the Shanghai Institute for Biomedical and Pharmaceutical Technologies, boasts a robust academic and professional journey. With a PhD from Shanghai University of Traditional Chinese Medicine, Zeng has devoted 14 years to advancing the key technologies and fundamental theories of traditional Chinese medicine preparations. Zeng’s work emphasizes novel dosage forms of traditional Chinese medicine, contributing to significant scientific advancements. Beyond research, Zeng holds part-time social positions as a review expert for China National Knowledge Internet and a member of various esteemed organizations, including the Shanghai Science and Technology Expert Database and the Industrial Pharmacy Group within the Shanghai Pharmaceutical Association. Zeng is also a reviewer for international publications, ensuring the dissemination of high-quality scientific knowledge. Through extensive collaboration and leadership in numerous research projects, Jia Zeng continues to impact the field of traditional Chinese medicine profoundly.
Publication Profile
Orcid
Education
Jia Zeng graduated with a PhD from Shanghai University of Traditional Chinese Medicine, where the foundation of a prolific career in traditional Chinese medicine (TCM) research was laid. This academic background has been instrumental in Zeng’s in-depth understanding of the key technologies and fundamental theories of TCM preparations. The rigorous training and education received during the PhD program equipped Zeng with the skills necessary to explore novel dosage forms and advance the scientific knowledge in this field. Additionally, the academic journey at Shanghai University of Traditional Chinese Medicine provided opportunities for engaging in various research projects and collaborating with experts, further enriching Zeng’s educational experience. This strong educational background has been a cornerstone of Zeng’s contributions to TCM, enabling the pursuit of innovative solutions and the development of new drugs, thereby cementing Zeng’s status as a leading researcher in the field.
Experience
Jia Zeng has amassed 14 years of experience at the Shanghai Institute for Biomedical and Pharmaceutical Technologies, specializing in the research of key technologies and fundamental theories of traditional Chinese medicine (TCM) preparations. Zeng has presided over more than 10 scientific research projects, including those funded by the Shanghai Municipal Science and Technology Commission and the Shanghai Municipal Health Commission. Additionally, Zeng has participated in over 20 projects, including collaborations funded by the Bill Gates and Melinda Gates Foundation. Notable projects include the Class 1.1 Innovative TCM Drug project titled “Zhibai Qingliang Granules.” With a robust H-index of 12, Zeng has published 51 papers in academic journals, 28 as first or corresponding author. The professional journey is marked by extensive collaboration with Chinese pharmaceutical companies and participation in international projects, solidifying Zeng’s role as a pivotal figure in TCM research and innovation.
Research focus
Jia Zeng’s research focuses on the key technologies and fundamental theories of traditional Chinese medicine (TCM) preparations, with a particular emphasis on developing novel dosage forms. This involves exploring innovative methodologies to enhance the efficacy and delivery of TCM. Zeng has established two significant technology research platforms: the Long-Acting Formulation Release Correlation Platform and the Computer Simulation Research Platform. The former investigates the in vitro-in vivo correlation of formulations and studies the link between long-term and accelerated drug release in vitro. The latter introduces fresh methods for the scientific design and rational development of TCM preparations, significantly reducing the resources required. Zeng’s research is characterized by the novel approaches and strategies employed, addressing the scarcity of existing experience in these areas. This dedication to advancing TCM preparation technologies underscores Zeng’s impact on the field, driving forward the scientific understanding and application of TCM.
Publication Top Notes
📘 Silkworm Cocoon: Dual Functions as a Traditional Chinese Medicine and the Raw Material of Promising Biocompatible Carriers
📘 Current Progress and Outlook for Agrimonolide: A Promising Bioactive Compound from Agrimonia pilosa Ledeb.
📘 Empirical Prediction Model Based Process Optimization for Droplet Size and Spraying Angle During Pharmaceutical Fluidized Bed Granulation DOI: 10.1080/10837450.2020.1738461
📘 Current Knowledge and Development of Hederagenin as a Promising Medicinal Agent: A Comprehensive Review